The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Spasmipur 20 mg/ml solution for injection

20 milligram(s)/millilitre Solution for injection

Richter Pharma AGVPA10801/013/001

Main Information

Trade NameSpasmipur 20 mg/ml solution for injection
Active SubstancesHyoscine butylbromide
Strength20 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderRichter Pharma AG
Licence NumberVPA10801/013/001

Group Information

ATC CodeQA03BB01 butylscopolamine
Therapeutic ClassAlimentary Tract Preparation


Licence Issued10/05/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back